Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies
This literature review answers a series of questions on the prevalence of chronic HBV and HCV infection in the general EU population, the number of individuals with chronic HBV or HCV infection, and current national practices for screening for chronic HBV and HCV infection, all with the overarching goal of promoting national and European policies on the secondary prevention of these two diseases.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.